Lv1
40 积分 2025-04-25 加入
Achieving control of nasopharyngeal carcinoma: the role of Epstein–Barr virus-based screening and vaccines
5天前
已完结
Epstein–Barr virus-mediated immune evasion in tumor promotion
4个月前
已完结
Efficacy and Safety of Cell-based Immunotherapy in The Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma – A Systematic Review and Meta-analysis
4个月前
已完结
Tumor immune microenvironment remodeling after neoadjuvant therapy in gastric cancer: Update and new challenges
4个月前
已完结
Induction chemotherapy for nasopharyngeal carcinoma
4个月前
已关闭
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial
5个月前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
5个月前
已完结
Facts and hopes in neoadjuvant immunotherapy combinations in resectable non-small-cell lung cancer
5个月前
已完结
皖公网安备34019202002308
